Meta Platforms Inc

Meta Platforms’ strategy blends edge‑computing, AI‑curation, and $2.1 B in original content to boost streaming, AR/VR and ad revenue—positioning the firm as a future‑proof media player.

Meta Platforms’ cautious consolidation: steady ad revenue, rising regulatory risk and privacy‑native growth hint at future upside—or hidden downside.

Meta settles Kentucky lawsuit over youth mental‑health claims, signaling a shift toward stronger age‑verification, parental controls and regulatory compliance.

Meta Platforms’ Q1 2026 outlook: AI‑boosted ads grow 33 % amid slowing user gains and rising regulatory costs, but strong cash flow keeps upside in reach.

Meta’s new ad‑tech suite boosts targeting, spend efficiency & privacy‑compliance, giving marketers richer data‑driven insights to outpace rivals.

Meta Platforms’ Q4 FY2026 highlights asset growth, rising mobile users, and a sharpened risk model—showing how fintech meets telecom‑media trends for lasting value.

Meta Platforms and Bristol Myers Squibb unite AI‑driven discovery with clinical expertise to accelerate oncology, hematology, and immunology therapies, a $15 billion partnership set to close 2026.

Meta Platforms’ Q1 2026 earnings reveal a strategic shift to biotech, driven by VYVGART’s expanding autoimmune sales, robust R&D, and Vision 2030 plans.

Meta’s lawsuit over its Llama AI model shows how copyright disputes can reshape content acquisition, AI infrastructure, and growth strategy.

Meta’s $13 bn “Sopaipilla” Texas data‑center: debt‑financing, AI focus, 800 MW power, 300 jobs, ESG challenges – how will it impact Meta’s future?